CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03088540
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-26T00:07:40.090580+00:00
Published At: 2026-06-25T00:00:00+00:00
Record Updated At: 2026-06-25
Results Posted At: 2026-06-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Carcinoma\uff0cNon-Small-Cell Lung", "Lung Carcinomas, Non-Small-Cell", "Non-small-cell Lung Carcinoma", "Nonsmall Cell Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-25"
protocolSection.identificationModule.nctId: "NCT03088540"
protocolSection.identificationModule.officialTitle: "A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell Lung Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.